KIDNEY-SPARING

Clinical trials for KIDNEY-SPARING explained in plain language.

Never miss a new study

Get alerted when new KIDNEY-SPARING trials appear

Sign up with your email to follow new studies for KIDNEY-SPARING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo aims to zap tumors, save kidneys

Disease control Recruiting now

This study is testing whether a combination of two drugs, tislelizumab and nab-paclitaxel, can effectively treat a type of kidney cancer located in the renal pelvis. The main goal is to control the cancer for at least one year while avoiding the need to surgically remove the enti…

Matched conditions: KIDNEY-SPARING

Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

KIDNEY-SPARING

Get alerted when new KIDNEY-SPARING trials appear

New combo aims to zap tumors, save kidneys